SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 8-K - Current report:
SEC Accession No. 0001193125-22-282752
Filing Date
2022-11-10
Accepted
2022-11-10 17:01:08
Documents
15
Period of Report
2022-11-10
Items
Item 2.02: Results of Operations and Financial Condition
Item 9.01: Financial Statements and Exhibits

Document Format Files

Seq Description Document Type Size
1 8-K d387879d8k.htm   iXBRL 8-K 25100
2 EX-99.1 d387879dex991.htm EX-99.1 91184
3 EX-99.2 d387879dex992.htm EX-99.2 33982
7 GRAPHIC g387879g16f15.jpg GRAPHIC 1393
  Complete submission text file 0001193125-22-282752.txt   292118

Data Files

Seq Description Document Type Size
4 XBRL TAXONOMY EXTENSION SCHEMA ttoo-20221110.xsd EX-101.SCH 2873
5 XBRL TAXONOMY EXTENSION LABEL LINKBASE ttoo-20221110_lab.xml EX-101.LAB 17237
6 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE ttoo-20221110_pre.xml EX-101.PRE 10824
9 EXTRACTED XBRL INSTANCE DOCUMENT d387879d8k_htm.xml XML 3225
Mailing Address 101 HARTWELL AVENUE LEXINGTON MA 02421
Business Address 101 HARTWELL AVENUE LEXINGTON MA 02421 781-457-1200
T2 Biosystems, Inc. (Filer) CIK: 0001492674 (see all company filings)

IRS No.: 204827488 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 001-36571 | Film No.: 221378303
SIC: 3841 Surgical & Medical Instruments & Apparatus